Le Lézard
Classified in: Health
Subject: SVY

Global Medical Education Market 2018-2022 - Key Vendors are Harvard, Johns Hopkins, Oxford University, School of Clinical Medicine, University of Cambridge & Stanford University


DUBLIN, Sept 20, 2018 /PRNewswire/ --

Research and Markets Logo. (PRNewsFoto/Research and Markets) (PRNewsfoto/Research and Markets)

The "Global Medical Education Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

The Global Medical Education Market to grow at a CAGR of 16.71% during the period 2018-2022.

Global Medical Education Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

According to the report, one driver influencing this market is the increasing enrolment in medical sources. There has been an increase in interest in medical courses in recent years. In the US, the number of applications for medical schools estimated at 90,000 in 2017.

Using visual technologies for medical education is the latest trend Visual technologies such as augmented reality can improve training as well as the interaction between medical practitioners and patients. AR can also help medical trainees in performing accurate diagnosis.

Further, the report states that one challenge affecting this market is the high cost of education. Medical education degrees span numerous years for varied courses across countries. The four-year cost of medical schools in the US is estimated to be USD 0.30 million. Hence, the high tuition costs and the prolonged period for return on investment can be deterrent for students opting for medical education.


Key vendors

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

PART 05: MARKET SIZING

PART 06: FIVE FORCES ANALYSIS

PART 07: MARKET SEGMENTATION BY COURSES

PART 08: CUSTOMER LANDSCAPE

PART 09: MARKET SEGMENTATION BY LEARNING MODEL

PART 10: REGIONAL LANDSCAPE

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

PART 13: MARKET TRENDS
PART 14: VENDOR LANDSCAPE

PART 15: VENDOR ANALYSIS

For more information about this report visit

https://www.researchandmarkets.com/research/hqzzmd/global_medical?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:


Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 

SOURCE Research and Markets


These press releases may also interest you

at 07:05
Three major challenges poised to confront the nation's clinical laboratories, genetic test companies, and anatomic pathology laboratories will be major topics when a top-flight roster of lab experts, innovators, and lab leaders gather in New Orleans...

at 07:05
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that second quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday,...

at 07:04
Merck , known as MSD outside the United States and Canada, announced that Health Canada has granted approval of  KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with fluoropyrimidine- and platinum-containing-chemotherapy, for the...

at 07:00
Globe Life Inc. will release First Quarter 2024 earnings after the market closes on Monday, April 22, 2024.  At that time, a copy of the Company's First Quarter 2024 earnings press release and any other financial and statistical information about...

at 07:00
GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has granted the clinical trial approval for GFH925 (KRAS G12C inhibitor) in a...

at 07:00
César A. Lara, MD, introduces a groundbreaking solution for pain relief in the Tampa Bay area. Red Laser Therapy leverages the power of medical-grade red laser light to effectively address various types of pain, providing patients with a noninvasive...



News published on and distributed by: